Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 871 Records) |
Query Trace: Clopidogrel[original query] |
---|
Empiric treatment with aspirin and ticagrelor is the most cost-effective strategy in patients with minor stroke or transient ischemic attack. International journal of stroke : official journal of the International Stroke Society 2023 9 17474930231202374. Kaavya Narasimhalu, Jeremy Chan, Yoong Kwei Ang, Deidre Anne De Silva, Kelvin Bryan T |
Implication of diabetic status on platelet reactivity and clinical outcomes after drug-eluting stent implantation: results from the PTRG-DES consortium. Cardiovascular diabetology 2023 9 22 (1): 245. Ki-Hyun Jeon, Young-Hoon Jeong, In-Ho Chae, Byeong-Keuk Kim, Hyung Joon Joo, Kiyuk Chang, Yongwhi Park, Young Bin Song, Sung Gyun Ahn, Sang Yeub Lee, Jung Rae Cho, Ae-Young Her, Hyo-Soo Kim, Moo Hyun Kim, Do-Sun Lim, Eun-Seok Shin, Jung-Won Suh, |
Pharmacokinetic and Pharmacogenetic Predictors of Major Bleeding Events in Patients with an Acute Coronary Syndrome and Atrial Fibrillation Receiving Combined Antithrombotic Therapy. Journal of personalized medicine 2023 9 13 (9): . Olga Baturina, Maria Chashkina, Denis Andreev, Karin Mirzaev, Alexandra Bykova, Alexandr Suvorov, Daria Yeryshova, Svetlana Suchkova, Dmitry Sychev, Abram Syrk |
Non-Random Enrichment of Single-Nucleotide Polymorphisms Associated with Clopidogrel Resistance within Risk Loci Linked to the Severity of Underlying Cardiovascular Diseases: The Role of Admixture. Genes 2023 9 14 (9): . Mariangeli Monero-Paredes, Roberto Feliu-Maldonado, Kelvin Carrasquillo-Carrion, Pablo Gonzalez, Igor B Rogozin, Abiel Roche-Lima, Jorge Ducon |
CYP2C19 loss-of-function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel. Clinical and translational science 2023 8 . Markus Ramste, Markus Ritvos, Sergei Häyrynen, Johanna I Kiiski, Mikko Niemi, Juha Sinisa |
Dual Antiplatelet Therapies and Causes in Minor Stroke or Transient Ischemic Attack: A Prespecified Analysis in the CHANCE-2 Trial. Stroke 2023 8 . Xuewei Xie, Jing Jing, Xia Meng, S Claiborne Johnston, Philip M Bath, Zixiao Li, Xingquan Zhao, Liping Liu, Yilong Wang, Qin Xu, Anxin Wang, Yong Jiang, Hao Li, Yongjun Wang, |
CYP2C19 Loss-of-Function Variants Associated with Long-term Ischemic Stroke Events During Clopidogrel Treatment in the Chinese Population. Clinical pharmacology and therapeutics 2023 8 . Peng Wu, Ziqing Liu, Zijian Tian, Benrui Wu, Jian Shao, Qian Li, Zhaoxu Geng, Ying Pan, Ke Lu, Qiang Wang, Tao Xu, Kaixin Zh |
Implications of Pharmacogenetic Testing for Clopidogrel Therapy in a Tertiary Healthcare Hospital in North India. Cureus 2023 8 15 (7): e42169. Jayachandra Amarapalli, Prabhat Sharma, Rajat Datta, Anuka Shar |
Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis. BMC neurology 2023 8 23 (1): 303. Mingxia Li, Qianru Yang, Jiankuan Shi, Xiaolong Zhang, Hong Lin, Fangfang |
Effects of remnant cholesterol on the efficacy of genotype-guided dual antiplatelet in CYP2C19 loss-of -function carriers with minor stroke or transient ischaemic attack: a post-hoc analysis of the CHANCE-2 trial. EClinicalMedicine 2023 12 67 102357. Anxin Wang, Xue Tian, Xuewei Xie, Hao Li, Jing Jing, Jinxi Lin, Yilong Wang, Xingquan Zhao, Zixiao Li, Liping Liu, Yongjun Wang, Xia Me |
Investigation of genomic and transcriptomic risk factors in clopidogrel response in African Americans. medRxiv : the preprint server for health sciences 2023 12 . Guang Yang, Cristina Alarcon, Catherine Chanfreau, Norman H Lee, Paula Friedman, Edith Nutescu, Matthew Tuck, Travis O'Brien, Li Gong, Teri E Klein, Kyong-Mi Chang, Philip S Tsao, David O Meltzer, , Sony Tuteja, Minoli A Pere |
Utility of the ACD-GENE-CLI Score in Asian Patients with Critical Limb Ischemia Undergoing Endovascular Interventions. Journal of atherosclerosis and thrombosis 2023 12 . Wei-Ting Chang, Po-Sen Huang, Li-Wei Su, Chia-Te Liao, Han Siong Toh, Yi-Chen Chen, Chung-Han Ho, Zhih-Cherng Chen, Po-Chao Hsu, Chon-Seng Ho |
Cytochrome P-450 CYP2C19 genetic polymorphism and its relation with clopidogrel resistance. JPMA. The Journal of the Pakistan Medical Association 2023 12 73 (12): 2388-2392. Usman Nawaz, Mudassar Noor, Akbar Wahe |
Impact of CYP2C19 Genotype on Efficacy and Safety of Clopidogrel-based Antiplatelet Therapy in Stroke or Transient Ischemic Attack Patients: An Updated Systematic Review and Meta-analysis of Non-East Asian Studies. Cardiovascular drugs and therapy 2023 12 . Sarah Cargnin, Federica Ferrari, Salvatore Terrazzi |
Pharmacogenomic evaluation of CYP2C19 alleles linking low clopidogrel response and the risk of acute coronary syndrome in Indians. The journal of gene medicine 2023 11 e3634. Keshavamurthy Ganapathy Bhat, Ratheesh Kumar Janardhana Pillai, Heemanshu Lodhi, Vivek Singh Guleria, Anil Kumar Abbot, Love Gupta, Garima Rastogi, Anuka Sharma, Zafar Mohammed, Varun Shar |
CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention (PCI) in the Million Veterans Program. medRxiv : the preprint server for health sciences 2023 11 . Catherine Chanfreau-Coffinier, Kevin A Friede, Mary E Plomondon, Kyung Min Lee, Zhenyu Lu, Julie A Lynch, Scott L DuVall, Jason L Vassy, Stephen W Waldo, John H Cleator, Thomas M Maddox, Daniel J Rader, Themistocles L Assimes, Scott M Damrauer, Philip S Tsao, Kyong-Mi Chang, Deepak Voora, Jay Giri, Sony Tute |
Role of genetic polymorphisms in clopidogrel response variability: a systematic review. Open heart 2023 11 10 (2): . Jose Lopez, Justin Mark, Gustavo J Duarte, Mohammed Shaban, Franklin Sosa, Rishabh Mishra, Swati Jain, An Tran, Asma Khizar, Daniel Karpel, Giancarlo Acosta, Miguel Rodriguez-Guer |
Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes. Pharmacogenomics and personalized medicine 2023 10 16 901-909. Ismail Mouhrach, Laila Bouguenouch, Adil Kamal, Abbassi Meriame, Nada El Khorb, Mohammed El Azami El Idrissi, Hafid Akoudad, Hicham Bekka |
CYP2C19 Genotype Prevalence and Association With Recurrent Myocardial Infarction in British-South Asians Treated With Clopidogrel. JACC. Advances 2023 10 2 (7): None. Emma F Magavern, Benjamin Jacobs, Helen Warren, Gherardo Finocchiaro, Sarah Finer, David A van Heel, , Damian Smedley, Mark J Caulfie |
The Clinical Implementation of CYP2C19 Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry. Journal of cardiovascular pharmacology and therapeutics 2023 10 28 10742484231210704. Jaouad Azzahhafi, Wout W A van den Broek, Dean R P P Chan Pin Yin, Ankie M Harmsze, Ron H N van Schaik, Jurriën M Ten Be |
Ticagrelor Versus Clopidogrel in Minor Stroke or Transient Ischemic Attack With Intracranial Artery Stenosis: A Post Hoc Analysis of CHANCE-2. Journal of the American Heart Association 2023 10 e031611. Chunjuan Wang, Weili Jia, Jing Jing, Xia Meng, Anxin Wang, Qin Xu, Xinmiao Zhang, Yuesong Pan, Xuewei Xie, S Claiborne Johnston, Philip M Bath, Jinxi Lin, Yong Jiang, Hao Li, Yilong Wang, Xingquan Zhao, Liping Liu, Zixiao Li, Yongjun Wang, |
The association of CYP2C19 LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: An updated meta-analysis. Clinical and translational science 2024 4 17 (4): e13792. Mohitosh Biswas, Md Shahadat Hossain, Tahsin Ahmed Rupok, Md Sabbir Hossain, Chonlaphat Sukas |
Effectiveness of Clopidogrel vs Alternative P2Y Inhibitors Based on the ABCD-GENE Score. Journal of the American College of Cardiology 2024 4 83 (15): 1370-1381. Cameron D Thomas, Francesco Franchi, Joseph S Rossi, Ellen C Keeley, R David Anderson, Amber L Beitelshees, Julio D Duarte, Luis Ortega-Paz, Yan Gong, Richard A Kerensky, Natasha Kulick, Caitrin W McDonough, Anh B Nguyen, Yehua Wang, Marshall Winget, William E Yang, Julie A Johnson, Almut G Winterstein, George A Stouffer, Dominick J Angiolillo, Craig R Lee, Larisa H Cavalla |
Pharmacogenetics at scale in real-world bioresources: CYP2C19 and clopidogrel outcomes in UK Biobank. Pharmacogenetics and genomics 2024 1 . Khaled F Bedair, Blair Smith, Colin N A Palmer, Alex S F Doney, Ewan R Pears |
High platelet reactivity strongly predicts early stent thrombosis in patients with drug-eluting stent implantation. Scientific reports 2024 1 14 (1): 520. Subin Lim, Soon Jun Hong, Ju Hyeon Kim, Jung-Joon Cha, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Byeong-Keuk Kim, Kiyuk Chang, Yongwhi Park, Young Bin Song, Sung Gyun Ahn, Jung-Won Suh, Sang Yeub Lee, Jung Rae Cho, Ae-Young Her, Young-Hoon Jeong, Hyo-Soo Kim, Moo Hyun Kim, Eun-Seok Shin, Do-Sun Lim, |
The diversity and clinical implications of genetic variants influencing clopidogrel bioactivation and response in the Emirati population. Human genomics 2024 1 18 (1): 2. Lubna Q Khasawneh, Habiba Alsafar, Hiba Alblooshi, Mushal Allam, George P Patrinos, Bassam R A |
Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago. Cardiology and therapy 2024 1 . Daniele Jones, Shana Persad-Ramdeensingh, Sheherazade Crystal Abrahim, Naveen Seecheran, Rajini Rani Haraksin |
A novel AllGlo probe-quantitative PCR method for detecting single nucleotide polymorphism in CYP2C19 to evaluate the antiplatelet activity of clopidogrel. Scientific reports 2024 1 14 (1): 2358. Hongwei Li, Yizhen Fang, Yongquan Chen, Yuning Lin, Zanxi Fang, Zhiyuan Lin, Huabin Xie, Zhongying Zha |
Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial. Stroke and vascular neurology 2024 1 . Xinmiao Zhang, Jing Jing, Anxin Wang, Xuewei Xie, S Claiborne Johnston, Hao Li, Philip M Bath, Qin Xu, Jinxi Lin, Yilong Wang, Xingquan Zhao, Zixiao Li, Yong Jiang, Liping Liu, Weifeng Chen, Xuhai Gong, Jianhua Li, Xinsheng Han, Xia Meng, Yongjun Wa |
The Impact of CYP2C19 Genotype on the Platelet Reactivity Index (PRI) among Chronic Coronary Syndromes (CCS) Patients Undergoing Percutaneous Coronary Intervention (PCI): Affectability of Rapid Genetic Testing. Cardiovascular drugs and therapy 2024 1 . Mohammed Ahmed Akkaif, Nur Aizati Athirah Daud, Dzul Azri Mohamed Noor, Abubakar Sha'aban, Muhamad Ali Sk Abdul Kader, Baharudin Ibrah |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: